AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ATENOLOL BP

13 registrations across 2 African markets— 0 active

Markets with ATENOLOL BP

Recent registrations

Brand / ProductMarketHolderStatusExpires
ATEN-50 50MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
RATENOL 100 TABLETS
TABLETS / 2X14
🇳🇬NigeriaSEAGREEN PHARMA LTD 3expiredAug 2021
SANOLOL 100 TABLET
TABLETS/1X28
🇳🇬NigeriaSANPHARM NIG. LTD 18expiredApr 2021
SANOLOL 50 TABLET
TABLETS/1X28
🇳🇬NigeriaSANPHARM NIG. LTD 18expiredApr 2021
HYPERLOK_50 50MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2019
HYPERLOK_100 100MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2019
TOTAMOL 50MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2010
OKAPRESS-100 100MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2009
ATENOLOL, 50 50MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2008
ATENOLOL-100 100MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2008
OKAPRESS-50 50MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2006
ATENOLOL 100MG TABLET
TABLET
🇲🇼MalawiexpiredAug 2002
ATENOLOL 50MG TABLET
TABLET
🇲🇼MalawiexpiredAug 2002

ATENOLOL BP in Africa — Regulatory Overview

ATENOLOL BP is registered across 2 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 0 (0%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.